Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 18
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Integrating multiple lines of evidence to assess the effects of maternal BMI on pregnancy and perinatal outcomes

  • Borges, Maria Carolina
  • Bustamante Pineda, Mariona
  • Vrijheid, Martine
  • Lawlor, Deborah
Background: Higher maternal pre-pregnancy body mass index (BMI) is associated with adverse pregnancy and perinatal outcomes. However, whether these associations are causal remains unclear. Methods: We explored the relation of maternal pre-/early-pregnancy BMI with 20 pregnancy and perinatal outcomes by integrating evidence from three different approaches (i.e. multivariable regression, Mendelian randomisation, and paternal negative control analyses), including data from over 400,000 women. Results: All three analytical approaches supported associations of higher maternal BMI with lower odds of maternal anaemia, delivering a small-for-gestational-age baby and initiating breastfeeding, but higher odds of hypertensive disorders of pregnancy, gestational hypertension, preeclampsia, gestational diabetes, pre-labour membrane rupture, induction of labour, caesarean section, large-for-gestational age, high birthweight, low Apgar score at 1 min, and neonatal intensive care unit admission. For example, higher maternal BMI was associated with higher risk of gestational hypertension in multivariable regression (OR = 1.67; 95% CI = 1.63, 1.70 per standard unit in BMI) and Mendelian randomisation (OR = 1.59; 95% CI = 1.38, 1.83), which was not seen for paternal BMI (OR = 1.01; 95% CI = 0.98, 1.04). Findings did not support a relation between maternal BMI and perinatal depression. For other outcomes, evidence was inconclusive due to inconsistencies across the applied approaches or substantial imprecision in effect estimates from Mendelian randomisation. Conclusions: Our findings support a causal role for maternal pre-/early-pregnancy BMI on 14 out of 20 adverse pregnancy and perinatal outcomes. Pre-conception interventions to support women maintaining a healthy BMI may reduce the burden of obstetric and neonatal complications. Funding: Medical Research Council, British Heart Foundation, European Research Council, National Institutes of Health, National Institute for Health Research, Research Council of Norway, Wellcome Trust., This study was supported by the MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_00032/05), British Heart Foundation (AA/18/1/34219), the European Research Council under the European Union’s Seventh Framework Programme (FP/2007–2013)/ERC Grant Agreement (Grant number 669545), the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733206 (LifeCycle), the US National Institutes of Health (R01 DK10324, U01 HG004415), the Bristol NIHR Biomedical Research Centre, and the Research Council of Norway through its Centres of Excellence funding scheme (project number 262700), and the Wellcome Trust [Grant number WT220390]. For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author-Accepted Manuscript version arising from this submission. MCB has received support from MRC Skills Development Fellowship (MR/P014054/1) and the University of Bristol Vice-Chancellor’s Fellowship. DAL is a British Heart Foundation Chair (CH/F/20/90003) and NIHR Senior Investigator (NF-0616–10102). JT is supported by an Academy of Medical Sciences (AMS) Springboard Award, which is supported by the AMS, the Wellcome Trust, GCRF, the Government Department of Business, Energy and Industrial Strategy, the British Heart Foundation and Diabetes UK [SBF004\1079]. RMF was funded by a Wellcome Trust and Royal Society Sir Henry Dale Fellowship (WT104150) and is now funded by a Wellcome Trust Senior Research Fellowship (WT220390). RG received funding from the Dutch Heart Foundation (grant number 2017T013), the Dutch Diabetes Foundation (grant number 2017.81.002), and the Netherlands Organization for Health Research and Development (NWO, ZonMW, grant number 543003109). VWVJ received a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). XL received support from the Nordic Center of Excellence in Health-Related e-Sciences. LS reports funding from a Carlsberg Foundation postdoctoral fellowship (CF15-0899). BF was supported by an Oak Foundation Fellowship and by a grant from the Novo Nordisk Foundation (12,955). MCM has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement number 947684). TAB is supported by the Medical Research Council (MRC) (UK) (MR/K501281/1), the NHMRC (Australia) (GNT1183074 and GNT1157714), and the British Heart Foundation Accelerator Award at the University of Bristol (AA/18/1/34219) and works in/is affiliated with a unit that is supported by the UK Medical Research Council (MC_UU_00011/6). LB is a senior research scholar from the Fonds de la recherche du Québec-Santé (FRQ-S) and a member of the FRQ-S-funded Centre de recherche du CHUS. MFH was supported by an American Diabetes Association (ADA) Pathways Accelerator Award (1–15-ACE-26). SEH and MCM are partly funded by the Research Council of Norway (project no. 320656) and through its Centres of Excellence funding scheme (project No 262700). JW and RMc are supported by the National Institute for Health and Care Research under its Applied Research Collaboration, Yorkshire and Humber (NIHR200166).
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Parental infertility and offspring cardiometabolic trajectories: a pooled analysis of three European cohorts

  • Hernáez, Álvaro
  • ElHakeem, Ahmed
  • Barros, Henrique
  • Vrijkotte, Tanja
  • Fraser, Abigail
  • Lawlor, Deborah A.
  • Magnus, Maria Christine
Objective To assess whether parental infertility is associated with differences in cardiometabolic trajectories in offspring. Design Pooled observational analysis in three prospective cohorts. Setting Three nationwide pregnancy cohorts. Patients A total of 14,609 singletons from the UK Avon Longitudinal Study of Parents and Children, the Portuguese Geraçao 21, and the Amsterdam Born Children and Their Development study. Each cohort contributed data up to ages 26, 12, and 13 years, respectively. Intervention Parental infertility is defined as time-to-pregnancy of ≥12 months (n = 1,392, 9.5%). Main Outcome Measures Trajectories of body mass index (BMI), waist circumference, systolic blood pressure, diastolic blood pressure, low-density lipoprotein cholesterol (LDL-C) level, high-density lipoprotein cholesterol (HDL-C) level, triglycerides level, and glucose level were compared in the offspring of couples with and without infertility. Trajectories were modeled using mixed-effects models with natural cubic splines adjusting for cohort, sex of the offspring, and maternal factors (age, BMI, smoking, educational level, parity, and ethnicity). Predicted levels of cardiometabolic traits up to 25 years of age were compared with parental infertility. Results Offspring of couples with infertility had increasingly higher BMI (difference in mean predicted levels by age 25 years: 1.09 kg/m2, 95% confidence interval [0.68–1.50]) and suggestively higher diastolic blood pressure at age 25 years (1.21 mmHg [−0.003 to 2.43]). Their LDL-C tended to be higher, and their HDL-C values tended to be lower over time (age: 25 years, LDL-C: 4.07% [−0.79 to 8.93]; HDL-C: −2.78% [−6.99 to 1.43]). At age 17 years, offspring of couples with infertility had higher waist circumference (1.05 cm [0.11–1.99]) and systolic blood pressure (age: 17 years; 0.93 mmHg [0.044–1.81]), but these differences attenuated at later ages. No intergroup differences in triglyceride and glucose level trajectories were observed. Further adjustment for paternal age, BMI, smoking, and educational level, and both parents’ histories of diabetes and hypertension in the cohort with this information available (Avon Longitudinal Study of Parents and Children) did not attenuate intergroup differences. Conclusion Offspring of couples with infertility relative to those of fertile couples have increasingly higher BMI over the years, suggestively higher blood pressure levels, and tend to have greater values of LDL-C and lower values of HDL-C with age. Infertilidad parental y trayectorias cardiometabólicas de la descendencia: análisis conjunto de tres cohortes europeas., Objetivo Evaluar si la infertilidad parental se asocia con diferencias en el comportamiento cardiometabólico en la descendencia. Diseño Análisis observacional agrupado en tres cohortes prospectivas. Entorno Tres cohortes de embarazos de ámbito nacional. Pacientes Un total de 14.609 hijos únicos del Estudio Longitudinal Avon de Padres e Hijos del Reino Unido, del estudio portugués Geracao 21, y del estudio Amsterdam Born Children and Their Development. Cada cohorte aportó datos hasta los 26, 12 y 13 años de edad, respectivamente. Intervención La infertilidad parental se define como un tiempo hasta el embarazo de R12 meses (n . 1.392, 9,5%). Principales medidas de resultados Se compararon las evoluciones del índice de masa corporal (IMC), el perímetro de cintura, la presión arterial sistólica, la presión arterial diastólica, el nivel de colesterol de lipoproteínas de baja densidad (LDL-C), el nivel de colesterol de lipoproteínas de alta densidad (HDL-C), el nivel de triglicéridos y el nivel de glucosa en la descendencia de parejas con y sin infertilidad. Las evoluciones se modelaron mediante modelos de efectos mixtos con splines cúbicos naturales ajustados por cohorte, sexo de la descendencia y factores maternos (edad, IMC, tabaquismo, nivel educativo, paridad y etnia). Los niveles predichos de rasgos cardiometabólicos hasta los 25 años de edad se compararon con la infertilidad parental. Resultados Los hijos de parejas con infertilidad tenían un IMC cada vez más elevado (diferencia en los niveles medios previstos a los 25 años: 1,09 kg/m2, intervalo de confianza del 95% [0,68-1,50]) y una presión arterial diastólica sugestivamente más alta a la edad de 25 años (1,21 mmHg [ 0,003 a 2,43]). Sus valores de LDL-C tendían a ser más altos, y sus valores de HDL-C tendían a ser más bajos con el tiempo (edad: 25 años, LDL-C: 4,07% [ 0,79 a 8,93];HDL-C: 2,78% [ 6,99 a 1,43]). A los 17 años, los hijos de parejas con infertilidad tenían un perímetro de cintura (1,05 cm [0,11-1,99]) y una presión arterial sistólica (edad: 17 años; 0,93 mmHg [0,044-1,81]) más elevados, pero estas diferencias se atenuaron a edades más avanzadas. No se observaron diferencias intergrupales en las evolucioness de los niveles de triglicéridos y glucosa. Los ajustes adicionales por edad paterna, IMC, tabaquismo y nivel educativo, así como los antecedentes de diabetes e hipertensión de ambos progenitores en la cohorte que disponía de esta información (Avon Longitudinal Study of Parents and Children) no atenuaron las diferencias intergrupales. Conclusiones Los hijos de parejas con infertilidad en relación con los de parejas fértiles tienen un IMC cada vez más elevado con los años, niveles de presión arterial sugestivamente más altos y tienden a tener valores mayores de LDL-C y menores de HDL-C con la edad., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Placental efflux transporters and antiseizure or antidepressant medication use impact birth weight in MoBa cohort

  • Hernández Hernández, Marta
  • Cohen, Jacqueline M.
  • Skåra, Karoline Hansen
  • Grindstad, Thea
  • Lee, Yunsung
  • Magnus, Per
  • Njølstad, Pål R.
  • Andreassen, Ole A.
  • Corfield, Elizabeth C.
  • Havdahl, Alexandra
  • Molden, Espen
  • Furu, Kari
  • Magnus, Maria Christine
  • Hernáez, Álvaro
Low birth weight raises neonatal risks and lifelong health issues and is linked to maternal medication use during pregnancy. We examined data from the Norwegian Mother, Father, and Child Cohort Study and the Medical Birth Registry of Norway, including 69,828 offspring with genotype data and 81,189 with maternal genotype data. We identified genetic risk variants in placental efflux transporters, calculated genetic scores based on alleles related to transporter activity, and assessed their interaction with prenatal use of antiseizure or antidepressant medication on offspring birth weight. Our study uncovered possible genetic variants in both offspring (rs3740066) and mothers (rs10248420; rs2235015) in placental efflux transporters (MRP2-ABCC2 and MDR1-ABCB1) that modulated the association between prenatal exposure to antiseizure medication and low birth weight in the offspring. Antidepressant exposure was associated with low birth weight, but there were no gene-drug interactions. The interplay between MRP2-ABCC2 and MDR1-ABCB1 variants and antiseizure medication may impact neonatal birth weight., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Telomere length in relation to fecundability and use of assisted reproductive technologies: the Norwegian mother, father, and child cohort study

  • Skåra, Karoline Hansen
  • Lee, Yunsung
  • Jugessur, Astanand
  • Gjessing, Håkon K.
  • Aviv, Abraham
  • Brumpton, Ben
  • Næss, Øyvind
  • Hernáez, Álvaro
  • Hanevik, Hans Ivar
  • Magnus, Per
  • Magnus, Maria Christine
Background Telomere length (TL) has been reported to be associated with conditions such as endometriosis and polycystic ovary syndrome, with some studies finding associations with shorter TL and others with longer TL. In men, studies mostly report associations between shorter TL and sperm quality. To our knowledge, no studies have thus far investigated associations between TL and fecundability or the use of assisted reproductive technologies (ART). Methods This study is based on the Norwegian Mother, Father, and Child Cohort (MoBa) Study and uses data from the Medical Birth Registry of Norway (MBRN). We included women (24,645 with genotype data and 1054 with TL measurements) and men (18,339 with genotype data and 965 with TL measurements) participating between 1998 and 2008. We investigated associations between leukocyte TL (LTL) and fecundability (defined as the probability to conceive within a given menstrual cycle), infertility (defined has having spent 12 months or more trying to conceive without success), and ART use. We also repeated the analyses using instrumental variables for LTL consisting of genetic risk scores for LTL and genetically predicted LTL. Results Approximately 11% of couples had experienced infertility and 4% had used ART. LTL was not associated with fecundability in women (fecundability ratio [FR], 0.98; 95% confidence interval [CI], 0.92–1.04) or men (FR, 0.99; CI, 0.93–1.06), nor with infertility in women (odds ratio [OR], 1.03; CI, 0.85–1.24) or men (OR, 1.05; CI, 0.87–1.28). We observed an increased likelihood of using ART with increasing LTL in men (OR, 1.22; CI, 1.03–1.46), but not in women (OR, 1.10; CI, 0.92–1.31). No significant associations were observed using the instrumental variables for LTL. Conclusions We found no indication that LTL is a suitable biomarker for assessing fecundability, infertility, or ART use. Additional studies are required to replicate the association observed between LTL and ART use in men., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Cardiovascular disease risk factors and infertility: multivariable analyses and one-sample Mendelian randomization analyses in the Trøndelag Health Study

  • Skåra, Karoline Hansen
  • Hernáez, Álvaro
  • Næss, Øyvind
  • Fraser, Abigail
  • Lawlor, Deborah A.
  • Burgess, Stephen
  • Brumpton, Ben
  • Magnus, Maria Christine
STUDY QUESTION Are cardiovascular disease (CVD) risk factors causally associated with higher risk of infertility among women and men? SUMMARY ANSWER We found evidence to support a causal relationship between smoking initiation and history of infertility in women. WHAT IS KNOWN ALREADY Several CVD risk factors are associated with history of infertility. Previous studies using Mendelian randomization (MR) further support a causal relationship between BMI and infertility in women. STUDY DESIGN, SIZE, DURATION We used data from the Trøndelag Health Study (HUNT) in Norway, a prospective population-based cohort study, including 26 811 women and 15 598 men participating in three survey collections in 1995–1997 (HUNT2), 2006–2008 (HUNT3), and 2017–2019 (HUNT4). PARTICIPANTS/MATERIALS, SETTING, METHODS Our outcome was women’s self-reported history of infertility, defined as ever having tried to conceive for 12 months or more or having used ART. We assigned the history of infertility reported by women to their male partners; therefore, the measure of infertility was on the couple level. We used both conventional multivariable analyses and one-sample MR analyses to evaluate the association between female and male CVD risk factors (including BMI, blood pressure, lipid profile measurements, and smoking behaviours) and history of infertility in women and men, separately. MAIN RESULTS AND THE ROLE OF CHANCE A total of 4702 women (18%) and 2508 men (16%) were classified with a history of infertility. We found a higher risk of infertility among female smokers compared to non-smokers in both multivariable and MR analyses (odds ratio (OR) in multivariable analysis, 1.20; 95% CI, 1.12–1.28; OR in MR analysis, 1.13; CI, 1.02–1.26), and potentially for higher BMI (OR in multivariable analysis, 1.13; CI, 1.09–1.18; OR in MR analysis, 1.11, CI, 0.92–1.34). In multivariable analysis in women, we also found evidence of associations between triglyceride levels, high-density lipoprotein cholesterol, lifetime smoking index, and smoking intensity with higher risk of infertility. However, these results were not consistent in MR analyses. We found no robust or consistent associations between male CVD risk factors and infertility. LIMITATIONS, REASONS FOR CAUTION Our main limitation was that the CVD risk factors measured might not adequately capture the relevant time periods for when couples were trying to conceive. Additionally, we did not have information on causes of infertility in either women or men. WIDER IMPLICATIONS OF THE FINDINGS Women with infertility could have a worse CVD risk factor profile and thus public health interventions aimed at reducing the impact of some CVD risk factors, such as smoking and BMI, could reduce the burden of infertility. However, additional MR studies of the relationship between CVD risk factors and infertility with a larger sample size would be of value., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Impaired glucose tolerance and cardiovascular risk factors in relation to infertility: a Mendelian randomization analysis in the Norwegian Mother, Father, and Child Cohort Study

  • Hernáez, Álvaro
  • Lee, Yunsung
  • Page, Christian Magnus
  • Skåra, Karoline Hansen
  • Håberg, Siri Eldevik
  • Magnus, Per
  • Njølstad, Pål R.
  • Andreassen, Ole A.
  • Corfield, Elizabeth C.
  • Havdahl, Alexandra
  • Fraser, Abigail
  • Burgess, Stephen
  • Lawlor, Deborah A.
  • Magnus, Maria Christine
STUDY QUESTION Are impaired glucose tolerance (as measured by fasting glucose, glycated hemoglobin, and fasting insulin) and cardiovascular disease risk (as measured by low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, systolic blood pressure, and diastolic blood pressure) causally related to infertility? SUMMARY ANSWER Genetic instruments suggest that higher fasting insulin may increase infertility in women. WHAT IS KNOWN ALREADY Observational evidence suggests a shared etiology between impaired glucose tolerance, cardiovascular risk, and fertility problems. STUDY DESIGN, SIZE, DURATION This study included two-sample Mendelian randomization (MR) analyses, in which we used genome-wide association summary data that were publicly available for the biomarkers of impaired glucose tolerance and cardiovascular disease, and sex-specific genome-wide association studies (GWASs) of infertility conducted in the Norwegian Mother, Father, and Child Cohort Study. PARTICIPANTS/MATERIALS, SETTING, METHODS There were 68 882 women (average age 30, involved in 81 682 pregnancies) and 47 474 of their male partners (average age 33, 55 744 pregnancies) who had available genotype data and who provided self-reported information on time-to-pregnancy and use of ARTs. Of couples, 12% were infertile (having tried to conceive for ≥12 months or used ARTs to conceive). We applied the inverse variance weighted method with random effects to pool data across variants and a series of sensitivity analyses to explore genetic instrument validity. (We checked the robustness of genetic instruments and the lack of unbalanced horizontal pleiotropy, and we used methods that are robust to population stratification.) Findings were corrected for multiple comparisons by the Bonferroni method (eight exposures: P-value < 0.00625). MAIN RESULTS AND THE ROLE OF CHANCE In women, increases in genetically determined fasting insulin levels were associated with greater odds of infertility (+1 log(pmol/l): odds ratio 1.60, 95% CI 1.17 to 2.18, P-value = 0.003). The results were robust in the sensitivity analyses exploring the validity of MR assumptions and the role of pleiotropy of other cardiometabolic risk factors. There was also evidence of higher glucose and glycated hemoglobin causing infertility in women, but the findings were imprecise and did not pass our P-value threshold for multiple testing. The results for lipids and blood pressure were close to the null, suggesting that these did not cause infertility. LIMITATIONS, REASONS FOR CAUTION We did not know if underlying causes of infertility were in the woman, man, or both. Our analyses only involved couples who had conceived. We did not have data on circulating levels of cardiometabolic risk factors, and we opted to conduct an MR analysis using GWAS summary statistics. No sex-specific genetic instruments on cardiometabolic risk factors were available. Our results may be affected by selection and misclassification bias. Finally, the characteristics of our study sample limit the generalizability of our results to populations of non-European ancestry. WIDER IMPLICATIONS OF THE FINDINGS Treatments for lower fasting insulin levels may reduce the risk of infertility in women. STUDY FUNDING/COMPETING INTEREST(S) The MoBa Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Norwegian Ministry of Education and Research. This work was supported by the European Research Council [grant numbers 947684, 101071773, 293574, 101021566], the Research Council of Norway [grant numbers 262700, 320656, 274611], the South-Eastern Norway Regional Health Authority [grant numbers 2020022, 2021045], and the British Heart Foundation [grant numbers CH/F/20/90003, AA/18/1/34219]. Open Access funding was provided by the Norwegian Institute of Public Health. The funders had no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the article for publication. D.A.L. has received research support from National and International government and charitable bodies, Roche Diagnostics and Medtronic for research unrelated to the current work. O.A.A. has been a consultant to HealthLytix. The rest of the authors declare that no competing interests exist., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Body mass index and subfertility: multivariable regression and Mendelian randomization analyses in the Norwegian Mother, Father and Child Cohort Study

  • Hernáez, Álvaro
  • Rogne, Tormod
  • Skåra, Karoline Hansen
  • Håberg, Siri Eldevik
  • Page, Christian Magnus
  • Fraser, Abigail
  • Burgess, Stephen
  • Lawlor, Deborah A.
  • Magnus, Maria Christine
STUDY QUESTION What is the association between BMI and subfertility? SUMMARY ANSWER We observed a J-shaped relationship between BMI and subfertility in both sexes, when using both a standard multivariable regression and Mendelian randomization (MR) analysis. WHAT IS KNOWN ALREADY High BMI in both women and men is associated with subfertility in observational studies and this relationship is further substantiated by a few small randomized controlled trials of weight reduction and success of assisted reproduction. Women with low BMI also have lower conception rates with assisted reproduction technologies. STUDY DESIGN, SIZE, DURATION Cohort study (the Norwegian Mother, Father and Child Cohort Study), 28 341 women and 26 252 men, recruited from all over Norway between 1999 and 2008. PARTICIPANTS/MATERIALS, SETTING, METHODS Women (average age 30, average BMI 23.1 kg/m2) and men (average age 33, average BMI 25.5 kg/m2) had available genotype data and provided self-reported information on time-to-pregnancy and BMI. A total of 10% of couples were subfertile (time-to-pregnancy ≥12 months). MAIN RESULTS AND THE ROLE OF CHANCE Our findings support a J-shaped association between BMI and subfertility in both sexes using multivariable logistic regression models. Non-linear MR validated this relationship. A 1 kg/m2 greater genetically predicted BMI was linked to 18% greater odds of subfertility (95% CI 5% to 31%) in obese women (≥30.0 kg/m2) and 15% lower odds of subfertility (−24% to −2%) in women with BMI <20.0 kg/m2. A 1 kg/m2 higher genetically predicted BMI was linked to 26% greater odds of subfertility (8–48%) among obese men. Low genetically predicted BMI values were also related to greater subfertility risk in men at the lower end of the BMI distribution. A genetically predicted BMI of 23 and 25 kg/m2 was linked to the lowest subfertility risk in women and men, respectively. LIMITATIONS, REASONS FOR CAUTION The main limitations of our study were that we did not know whether the subfertility was driven by the women, men or both; the exclusive consideration of individuals of northern European ancestry; and the limited amount of participants with obesity or BMI values <20.0 kg/m2. WIDER IMPLICATIONS OF THE FINDINGS Our results support a causal effect of obesity on subfertility in women and men. Our findings also expand the current evidence by indicating that individuals with BMI values <20 kg/m2 may have an increased risk of subfertility. These results suggest that BMI values between 20 and 25 kg/m2 are optimal for a minimal risk of subfertility. STUDY FUNDING/COMPETING INTEREST(S) The MoBa Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Norwegian Ministry of Education and Research. This project received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation program (grant agreement No 947684). It was also partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700. Open Access funding was provided by the Folkehelseinstituttet/Norwegian Institute of Public Health. D.A.L. is a UK National Institute for Health Research Senior Investigator (NF-SI-0611-10196) and is supported by the US National Institutes of Health (R01 DK10324) and a European Research Council Advanced Grant (DevelopObese; 669545). The funders had no role in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. D.A.L. receives (or has received in the last 10 years) research support from National and International government and charitable bodies, Roche Diagnostics and Medtronic for research unrelated to the current work. The rest of the authors declare that no competing interests exist., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Parental genetically predicted liability for coronary heart disease and risk of adverse pregnancy outcomes: a cohort study

  • Hernáez, Álvaro
  • Skåra, Karoline Hansen
  • Page, Christian Magnus
  • Mitter, Vera R.
  • Hernández Hernández, Marta
  • Magnus, Per
  • Njølstad, Pål R.
  • Andreassen, Ole A.
  • Corfeld, Elizabeth C.
  • Havdahl, Alexandra
  • Næss, Øyvind
  • Brumpton, Ben
  • Åsvold, Bjørn Olav
  • Lawlor, Deborah A.
  • Fraser, Abigail
  • Magnus, Maria Christine
Background Adverse pregnancy outcomes (APO) may unmask or exacerbate a woman’s underlying risk for coronary heart disease (CHD). We estimated associations of maternal and paternal genetically predicted liability for CHD with lifelong risk of APOs. We hypothesized that associations would be found for women, but not their male partners (negative controls). Methods We studied up to 83,969‬ women (and up to 55,568‬ male partners) from the Norwegian Mother, Father and Child Cohort Study or the Trøndelag Health Study with genotyping data and lifetime history of any APO in their pregnancies (1967–2019) in the Medical Birth Registry of Norway (miscarriage, stillbirth, hypertensive disorders of pregnancy, gestational diabetes, small for gestational age, large for gestational age, and spontaneous preterm birth). Maternal and paternal genetic risk scores (GRS) for CHD were generated using 148 gene variants (p-value < 5 × 10−8, not in linkage disequilibrium). Associations between GRS for CHD and each APO were determined using logistic regression, adjusting for genomic principal components, in each cohort separately, and combined using fixed effects meta-analysis. Results One standard deviation higher GRS for CHD in women was related to increased risk of any hypertensive disorders of pregnancy (odds ratio [OR] 1.08, 95% confidence interval [CI] 1.05–1.10), pre-eclampsia (OR 1.08, 95% CI 1.05–1.11), and small for gestational age (OR 1.04, 95% CI 1.01–1.06). Imprecise associations with lower odds of large for gestational age (OR 0.98, 95% CI 0.96–1.00) and higher odds of stillbirth (OR 1.04, 95% CI 0.98–1.11) were suggested. These findings remained consistent after adjusting for number of total pregnancies and the male partners’ GRS and restricting analyses to stable couples. Associations for other APOs were close to the null. There was weak evidence of an association of paternal genetically predicted liability for CHD with spontaneous preterm birth in female partners (OR 1.02, 95% CI 0.99–1.05), but not with other APOs. Conclusions Hypertensive disorders of pregnancy, small for gestational age, and stillbirth may unmask women with a genetically predicted propensity for CHD. The association of paternal genetically predicted CHD risk with spontaneous preterm birth in female partners needs further exploration., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Smoking and infertility: multivariable regression and Mendelian randomization analyses in the Norwegian Mother, Father and Child Cohort Study

  • Hernáez, Álvaro
  • Wootton, Robyn E.
  • Page, Christian Magnus
  • Skåra, Karoline Hansen
  • Fraser, Abigail
  • Rogne, Tormod
  • Magnus, Per
  • Njølstad, Pål R.
  • Andreassen, Ole A.
  • Burgess, Stephen
  • Lawlor, Deborah A.
  • Magnus, Maria Christine
Objective To investigate the association between smoking and infertility. Design Prospective study. Setting Nationwide cohort. Patients 28,606 women and 27,096 men with questionnaire and genotype information from the Norwegian Mother, Father, and Child Cohort Study. Intervention Self-reported information on smoking (having ever smoked [both sexes], age at initiation [women only], cessation [women only], and cigarettes/week in current smokers [both sexes]) was gathered. Genetically predetermined levels or likelihood of presenting these traits were estimated for Mendelian randomization. Main outcome measure Infertility (time-to-pregnancy ≥12 months). Results Having ever smoked was unrelated to infertility in women or men. Higher smoking intensity in women was associated with greater infertility odds (+1 standard deviation [SD, 48 cigarettes/week]: odds ratio [OR]crude, 1.19; 95% confidence interval [CI] 1.11–1.28; ORadjusted 1.12; 95% CI, 1.03–1.21), also after adjusting for the partner’s tobacco use. Later smoking initiation (+1 SD [3.2 years]: ORcrude, 0.94; 95% CI, 0.88–0.99; ORadjusted 0.89; 95% CI, 0.84–0.95) and smoking cessation (vs. not quitting: ORcrude, 0.83; 95% CI, 0.75–0.91; ORadjusted, 0.83; 95% CI, 0.75–0.93) were linked to decreased infertility in women. Nevertheless, Mendelian randomization results were not directionally consistent for smoking intensity and cessation and were estimated imprecisely in the 2-sample approach. In men, greater smoking intensity was not robustly associated with infertility in multivariable regression and Mendelian randomization. Conclusions We did not find robust evidence of an effect of smoking on infertility. This may be due to a true lack of effect, weak genetic instruments, or other kinds of confounding. Tabaquismo e infertilidad: regresión multivariable y análisis de aleatorización mendeliana en el estudio de cohorte noruego de madre, padre e hijo., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Parental infertility and offspring cardiometabolic trajectories: a pooled analysis of three European cohorts

  • Hernáez, Álvaro
  • ElHakeem, Ahmed
  • Barros, Henrique
  • Vrijkotte, Tanja
  • Fraser, Abigail
  • Lawlor, Deborah A.
  • Magnus, Maria Christine
Objective To assess whether parental infertility is associated with differences in cardiometabolic trajectories in offspring. Design Pooled observational analysis in three prospective cohorts. Setting Three nationwide pregnancy cohorts. Patients A total of 14,609 singletons from the UK Avon Longitudinal Study of Parents and Children, the Portuguese Geraçao 21, and the Amsterdam Born Children and Their Development study. Each cohort contributed data up to ages 26, 12, and 13 years, respectively. Intervention Parental infertility is defined as time-to-pregnancy of ≥12 months (n = 1,392, 9.5%). Main Outcome Measures Trajectories of body mass index (BMI), waist circumference, systolic blood pressure, diastolic blood pressure, low-density lipoprotein cholesterol (LDL-C) level, high-density lipoprotein cholesterol (HDL-C) level, triglycerides level, and glucose level were compared in the offspring of couples with and without infertility. Trajectories were modeled using mixed-effects models with natural cubic splines adjusting for cohort, sex of the offspring, and maternal factors (age, BMI, smoking, educational level, parity, and ethnicity). Predicted levels of cardiometabolic traits up to 25 years of age were compared with parental infertility. Results Offspring of couples with infertility had increasingly higher BMI (difference in mean predicted levels by age 25 years: 1.09 kg/m2, 95% confidence interval [0.68–1.50]) and suggestively higher diastolic blood pressure at age 25 years (1.21 mmHg [−0.003 to 2.43]). Their LDL-C tended to be higher, and their HDL-C values tended to be lower over time (age: 25 years, LDL-C: 4.07% [−0.79 to 8.93]; HDL-C: −2.78% [−6.99 to 1.43]). At age 17 years, offspring of couples with infertility had higher waist circumference (1.05 cm [0.11–1.99]) and systolic blood pressure (age: 17 years; 0.93 mmHg [0.044–1.81]), but these differences attenuated at later ages. No intergroup differences in triglyceride and glucose level trajectories were observed. Further adjustment for paternal age, BMI, smoking, and educational level, and both parents’ histories of diabetes and hypertension in the cohort with this information available (Avon Longitudinal Study of Parents and Children) did not attenuate intergroup differences. Conclusion Offspring of couples with infertility relative to those of fertile couples have increasingly higher BMI over the years, suggestively higher blood pressure levels, and tend to have greater values of LDL-C and lower values of HDL-C with age. Infertilidad parental y trayectorias cardiometabólicas de la descendencia: análisis conjunto de tres cohortes europeas., Objetivo Evaluar si la infertilidad parental se asocia con diferencias en el comportamiento cardiometabólico en la descendencia. Diseño Análisis observacional agrupado en tres cohortes prospectivas. Entorno Tres cohortes de embarazos de ámbito nacional. Pacientes Un total de 14.609 hijos únicos del Estudio Longitudinal Avon de Padres e Hijos del Reino Unido, del estudio portugués Geracao 21, y del estudio Amsterdam Born Children and Their Development. Cada cohorte aportó datos hasta los 26, 12 y 13 años de edad, respectivamente. Intervención La infertilidad parental se define como un tiempo hasta el embarazo de R12 meses (n . 1.392, 9,5%). Principales medidas de resultados Se compararon las evoluciones del índice de masa corporal (IMC), el perímetro de cintura, la presión arterial sistólica, la presión arterial diastólica, el nivel de colesterol de lipoproteínas de baja densidad (LDL-C), el nivel de colesterol de lipoproteínas de alta densidad (HDL-C), el nivel de triglicéridos y el nivel de glucosa en la descendencia de parejas con y sin infertilidad. Las evoluciones se modelaron mediante modelos de efectos mixtos con splines cúbicos naturales ajustados por cohorte, sexo de la descendencia y factores maternos (edad, IMC, tabaquismo, nivel educativo, paridad y etnia). Los niveles predichos de rasgos cardiometabólicos hasta los 25 años de edad se compararon con la infertilidad parental. Resultados Los hijos de parejas con infertilidad tenían un IMC cada vez más elevado (diferencia en los niveles medios previstos a los 25 años: 1,09 kg/m2, intervalo de confianza del 95% [0,68-1,50]) y una presión arterial diastólica sugestivamente más alta a la edad de 25 años (1,21 mmHg [ 0,003 a 2,43]). Sus valores de LDL-C tendían a ser más altos, y sus valores de HDL-C tendían a ser más bajos con el tiempo (edad: 25 años, LDL-C: 4,07% [ 0,79 a 8,93];HDL-C: 2,78% [ 6,99 a 1,43]). A los 17 años, los hijos de parejas con infertilidad tenían un perímetro de cintura (1,05 cm [0,11-1,99]) y una presión arterial sistólica (edad: 17 años; 0,93 mmHg [0,044-1,81]) más elevados, pero estas diferencias se atenuaron a edades más avanzadas. No se observaron diferencias intergrupales en las evolucioness de los niveles de triglicéridos y glucosa. Los ajustes adicionales por edad paterna, IMC, tabaquismo y nivel educativo, así como los antecedentes de diabetes e hipertensión de ambos progenitores en la cohorte que disponía de esta información (Avon Longitudinal Study of Parents and Children) no atenuaron las diferencias intergrupales. Conclusiones Los hijos de parejas con infertilidad en relación con los de parejas fértiles tienen un IMC cada vez más elevado con los años, niveles de presión arterial sugestivamente más altos y tienden a tener valores mayores de LDL-C y menores de HDL-C con la edad., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Body mass index and subfertility: multivariable regression and Mendelian randomization analyses in the Norwegian Mother, Father and Child Cohort Study

  • Hernáez, Álvaro
  • Rogne, Tormod
  • Skåra, Karoline Hansen
  • Håberg, Siri Eldevik
  • Page, Christian Magnus
  • Fraser, Abigail
  • Burgess, Stephen
  • Lawlor, Deborah A.
  • Magnus, Maria Christine
STUDY QUESTION What is the association between BMI and subfertility? SUMMARY ANSWER We observed a J-shaped relationship between BMI and subfertility in both sexes, when using both a standard multivariable regression and Mendelian randomization (MR) analysis. WHAT IS KNOWN ALREADY High BMI in both women and men is associated with subfertility in observational studies and this relationship is further substantiated by a few small randomized controlled trials of weight reduction and success of assisted reproduction. Women with low BMI also have lower conception rates with assisted reproduction technologies. STUDY DESIGN, SIZE, DURATION Cohort study (the Norwegian Mother, Father and Child Cohort Study), 28 341 women and 26 252 men, recruited from all over Norway between 1999 and 2008. PARTICIPANTS/MATERIALS, SETTING, METHODS Women (average age 30, average BMI 23.1 kg/m2) and men (average age 33, average BMI 25.5 kg/m2) had available genotype data and provided self-reported information on time-to-pregnancy and BMI. A total of 10% of couples were subfertile (time-to-pregnancy ≥12 months). MAIN RESULTS AND THE ROLE OF CHANCE Our findings support a J-shaped association between BMI and subfertility in both sexes using multivariable logistic regression models. Non-linear MR validated this relationship. A 1 kg/m2 greater genetically predicted BMI was linked to 18% greater odds of subfertility (95% CI 5% to 31%) in obese women (≥30.0 kg/m2) and 15% lower odds of subfertility (−24% to −2%) in women with BMI <20.0 kg/m2. A 1 kg/m2 higher genetically predicted BMI was linked to 26% greater odds of subfertility (8–48%) among obese men. Low genetically predicted BMI values were also related to greater subfertility risk in men at the lower end of the BMI distribution. A genetically predicted BMI of 23 and 25 kg/m2 was linked to the lowest subfertility risk in women and men, respectively. LIMITATIONS, REASONS FOR CAUTION The main limitations of our study were that we did not know whether the subfertility was driven by the women, men or both; the exclusive consideration of individuals of northern European ancestry; and the limited amount of participants with obesity or BMI values <20.0 kg/m2. WIDER IMPLICATIONS OF THE FINDINGS Our results support a causal effect of obesity on subfertility in women and men. Our findings also expand the current evidence by indicating that individuals with BMI values <20 kg/m2 may have an increased risk of subfertility. These results suggest that BMI values between 20 and 25 kg/m2 are optimal for a minimal risk of subfertility. STUDY FUNDING/COMPETING INTEREST(S) The MoBa Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Norwegian Ministry of Education and Research. This project received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation program (grant agreement No 947684). It was also partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700. Open Access funding was provided by the Folkehelseinstituttet/Norwegian Institute of Public Health. D.A.L. is a UK National Institute for Health Research Senior Investigator (NF-SI-0611-10196) and is supported by the US National Institutes of Health (R01 DK10324) and a European Research Council Advanced Grant (DevelopObese; 669545). The funders had no role in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. D.A.L. receives (or has received in the last 10 years) research support from National and International government and charitable bodies, Roche Diagnostics and Medtronic for research unrelated to the current work. The rest of the authors declare that no competing interests exist., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Integrating multiple lines of evidence to assess the effects of maternal BMI on pregnancy and perinatal outcomes

  • Borges, Maria Carolina
  • Bustamante Pineda, Mariona
  • Vrijheid, Martine
  • Lawlor, Deborah
Background: Higher maternal pre-pregnancy body mass index (BMI) is associated with adverse pregnancy and perinatal outcomes. However, whether these associations are causal remains unclear. Methods: We explored the relation of maternal pre-/early-pregnancy BMI with 20 pregnancy and perinatal outcomes by integrating evidence from three different approaches (i.e. multivariable regression, Mendelian randomisation, and paternal negative control analyses), including data from over 400,000 women. Results: All three analytical approaches supported associations of higher maternal BMI with lower odds of maternal anaemia, delivering a small-for-gestational-age baby and initiating breastfeeding, but higher odds of hypertensive disorders of pregnancy, gestational hypertension, preeclampsia, gestational diabetes, pre-labour membrane rupture, induction of labour, caesarean section, large-for-gestational age, high birthweight, low Apgar score at 1 min, and neonatal intensive care unit admission. For example, higher maternal BMI was associated with higher risk of gestational hypertension in multivariable regression (OR = 1.67; 95% CI = 1.63, 1.70 per standard unit in BMI) and Mendelian randomisation (OR = 1.59; 95% CI = 1.38, 1.83), which was not seen for paternal BMI (OR = 1.01; 95% CI = 0.98, 1.04). Findings did not support a relation between maternal BMI and perinatal depression. For other outcomes, evidence was inconclusive due to inconsistencies across the applied approaches or substantial imprecision in effect estimates from Mendelian randomisation. Conclusions: Our findings support a causal role for maternal pre-/early-pregnancy BMI on 14 out of 20 adverse pregnancy and perinatal outcomes. Pre-conception interventions to support women maintaining a healthy BMI may reduce the burden of obstetric and neonatal complications. Funding: Medical Research Council, British Heart Foundation, European Research Council, National Institutes of Health, National Institute for Health Research, Research Council of Norway, Wellcome Trust., This study was supported by the MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_00032/05), British Heart Foundation (AA/18/1/34219), the European Research Council under the European Union’s Seventh Framework Programme (FP/2007–2013)/ERC Grant Agreement (Grant number 669545), the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733206 (LifeCycle), the US National Institutes of Health (R01 DK10324, U01 HG004415), the Bristol NIHR Biomedical Research Centre, and the Research Council of Norway through its Centres of Excellence funding scheme (project number 262700), and the Wellcome Trust [Grant number WT220390]. For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author-Accepted Manuscript version arising from this submission. MCB has received support from MRC Skills Development Fellowship (MR/P014054/1) and the University of Bristol Vice-Chancellor’s Fellowship. DAL is a British Heart Foundation Chair (CH/F/20/90003) and NIHR Senior Investigator (NF-0616–10102). JT is supported by an Academy of Medical Sciences (AMS) Springboard Award, which is supported by the AMS, the Wellcome Trust, GCRF, the Government Department of Business, Energy and Industrial Strategy, the British Heart Foundation and Diabetes UK [SBF004\1079]. RMF was funded by a Wellcome Trust and Royal Society Sir Henry Dale Fellowship (WT104150) and is now funded by a Wellcome Trust Senior Research Fellowship (WT220390). RG received funding from the Dutch Heart Foundation (grant number 2017T013), the Dutch Diabetes Foundation (grant number 2017.81.002), and the Netherlands Organization for Health Research and Development (NWO, ZonMW, grant number 543003109). VWVJ received a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). XL received support from the Nordic Center of Excellence in Health-Related e-Sciences. LS reports funding from a Carlsberg Foundation postdoctoral fellowship (CF15-0899). BF was supported by an Oak Foundation Fellowship and by a grant from the Novo Nordisk Foundation (12,955). MCM has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement number 947684). TAB is supported by the Medical Research Council (MRC) (UK) (MR/K501281/1), the NHMRC (Australia) (GNT1183074 and GNT1157714), and the British Heart Foundation Accelerator Award at the University of Bristol (AA/18/1/34219) and works in/is affiliated with a unit that is supported by the UK Medical Research Council (MC_UU_00011/6). LB is a senior research scholar from the Fonds de la recherche du Québec-Santé (FRQ-S) and a member of the FRQ-S-funded Centre de recherche du CHUS. MFH was supported by an American Diabetes Association (ADA) Pathways Accelerator Award (1–15-ACE-26). SEH and MCM are partly funded by the Research Council of Norway (project no. 320656) and through its Centres of Excellence funding scheme (project No 262700). JW and RMc are supported by the National Institute for Health and Care Research under its Applied Research Collaboration, Yorkshire and Humber (NIHR200166).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Impaired glucose tolerance and cardiovascular risk factors in relation to infertility: a Mendelian randomization analysis in the Norwegian Mother, Father, and Child Cohort Study

  • Hernáez, Álvaro
  • Lee, Yunsung
  • Page, Christian Magnus
  • Skåra, Karoline Hansen
  • Håberg, Siri Eldevik
  • Magnus, Per
  • Njølstad, Pål R.
  • Andreassen, Ole A.
  • Corfield, Elizabeth C.
  • Havdahl, Alexandra
  • Fraser, Abigail
  • Burgess, Stephen
  • Lawlor, Deborah A.
  • Magnus, Maria Christine
STUDY QUESTION Are impaired glucose tolerance (as measured by fasting glucose, glycated hemoglobin, and fasting insulin) and cardiovascular disease risk (as measured by low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, systolic blood pressure, and diastolic blood pressure) causally related to infertility? SUMMARY ANSWER Genetic instruments suggest that higher fasting insulin may increase infertility in women. WHAT IS KNOWN ALREADY Observational evidence suggests a shared etiology between impaired glucose tolerance, cardiovascular risk, and fertility problems. STUDY DESIGN, SIZE, DURATION This study included two-sample Mendelian randomization (MR) analyses, in which we used genome-wide association summary data that were publicly available for the biomarkers of impaired glucose tolerance and cardiovascular disease, and sex-specific genome-wide association studies (GWASs) of infertility conducted in the Norwegian Mother, Father, and Child Cohort Study. PARTICIPANTS/MATERIALS, SETTING, METHODS There were 68 882 women (average age 30, involved in 81 682 pregnancies) and 47 474 of their male partners (average age 33, 55 744 pregnancies) who had available genotype data and who provided self-reported information on time-to-pregnancy and use of ARTs. Of couples, 12% were infertile (having tried to conceive for ≥12 months or used ARTs to conceive). We applied the inverse variance weighted method with random effects to pool data across variants and a series of sensitivity analyses to explore genetic instrument validity. (We checked the robustness of genetic instruments and the lack of unbalanced horizontal pleiotropy, and we used methods that are robust to population stratification.) Findings were corrected for multiple comparisons by the Bonferroni method (eight exposures: P-value < 0.00625). MAIN RESULTS AND THE ROLE OF CHANCE In women, increases in genetically determined fasting insulin levels were associated with greater odds of infertility (+1 log(pmol/l): odds ratio 1.60, 95% CI 1.17 to 2.18, P-value = 0.003). The results were robust in the sensitivity analyses exploring the validity of MR assumptions and the role of pleiotropy of other cardiometabolic risk factors. There was also evidence of higher glucose and glycated hemoglobin causing infertility in women, but the findings were imprecise and did not pass our P-value threshold for multiple testing. The results for lipids and blood pressure were close to the null, suggesting that these did not cause infertility. LIMITATIONS, REASONS FOR CAUTION We did not know if underlying causes of infertility were in the woman, man, or both. Our analyses only involved couples who had conceived. We did not have data on circulating levels of cardiometabolic risk factors, and we opted to conduct an MR analysis using GWAS summary statistics. No sex-specific genetic instruments on cardiometabolic risk factors were available. Our results may be affected by selection and misclassification bias. Finally, the characteristics of our study sample limit the generalizability of our results to populations of non-European ancestry. WIDER IMPLICATIONS OF THE FINDINGS Treatments for lower fasting insulin levels may reduce the risk of infertility in women. STUDY FUNDING/COMPETING INTEREST(S) The MoBa Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Norwegian Ministry of Education and Research. This work was supported by the European Research Council [grant numbers 947684, 101071773, 293574, 101021566], the Research Council of Norway [grant numbers 262700, 320656, 274611], the South-Eastern Norway Regional Health Authority [grant numbers 2020022, 2021045], and the British Heart Foundation [grant numbers CH/F/20/90003, AA/18/1/34219]. Open Access funding was provided by the Norwegian Institute of Public Health. The funders had no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the article for publication. D.A.L. has received research support from National and International government and charitable bodies, Roche Diagnostics and Medtronic for research unrelated to the current work. O.A.A. has been a consultant to HealthLytix. The rest of the authors declare that no competing interests exist., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Smoking and infertility: multivariable regression and Mendelian randomization analyses in the Norwegian Mother, Father and Child Cohort Study

  • Hernáez, Álvaro
  • Wootton, Robyn E.
  • Page, Christian Magnus
  • Skåra, Karoline Hansen
  • Fraser, Abigail
  • Rogne, Tormod
  • Magnus, Per
  • Njølstad, Pål R.
  • Andreassen, Ole A.
  • Burgess, Stephen
  • Lawlor, Deborah A.
  • Magnus, Maria Christine
Objective To investigate the association between smoking and infertility. Design Prospective study. Setting Nationwide cohort. Patients 28,606 women and 27,096 men with questionnaire and genotype information from the Norwegian Mother, Father, and Child Cohort Study. Intervention Self-reported information on smoking (having ever smoked [both sexes], age at initiation [women only], cessation [women only], and cigarettes/week in current smokers [both sexes]) was gathered. Genetically predetermined levels or likelihood of presenting these traits were estimated for Mendelian randomization. Main outcome measure Infertility (time-to-pregnancy ≥12 months). Results Having ever smoked was unrelated to infertility in women or men. Higher smoking intensity in women was associated with greater infertility odds (+1 standard deviation [SD, 48 cigarettes/week]: odds ratio [OR]crude, 1.19; 95% confidence interval [CI] 1.11–1.28; ORadjusted 1.12; 95% CI, 1.03–1.21), also after adjusting for the partner’s tobacco use. Later smoking initiation (+1 SD [3.2 years]: ORcrude, 0.94; 95% CI, 0.88–0.99; ORadjusted 0.89; 95% CI, 0.84–0.95) and smoking cessation (vs. not quitting: ORcrude, 0.83; 95% CI, 0.75–0.91; ORadjusted, 0.83; 95% CI, 0.75–0.93) were linked to decreased infertility in women. Nevertheless, Mendelian randomization results were not directionally consistent for smoking intensity and cessation and were estimated imprecisely in the 2-sample approach. In men, greater smoking intensity was not robustly associated with infertility in multivariable regression and Mendelian randomization. Conclusions We did not find robust evidence of an effect of smoking on infertility. This may be due to a true lack of effect, weak genetic instruments, or other kinds of confounding. Tabaquismo e infertilidad: regresión multivariable y análisis de aleatorización mendeliana en el estudio de cohorte noruego de madre, padre e hijo., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Placental efflux transporters and antiseizure or antidepressant medication use impact birth weight in MoBa cohort

  • Hernández Hernández, Marta
  • Cohen, Jacqueline M.
  • Skåra, Karoline Hansen
  • Grindstad, Thea
  • Lee, Yunsung
  • Magnus, Per
  • Njølstad, Pål R.
  • Andreassen, Ole A.
  • Corfield, Elizabeth C.
  • Havdahl, Alexandra
  • Molden, Espen
  • Furu, Kari
  • Magnus, Maria Christine
  • Hernáez, Álvaro
Low birth weight raises neonatal risks and lifelong health issues and is linked to maternal medication use during pregnancy. We examined data from the Norwegian Mother, Father, and Child Cohort Study and the Medical Birth Registry of Norway, including 69,828 offspring with genotype data and 81,189 with maternal genotype data. We identified genetic risk variants in placental efflux transporters, calculated genetic scores based on alleles related to transporter activity, and assessed their interaction with prenatal use of antiseizure or antidepressant medication on offspring birth weight. Our study uncovered possible genetic variants in both offspring (rs3740066) and mothers (rs10248420; rs2235015) in placental efflux transporters (MRP2-ABCC2 and MDR1-ABCB1) that modulated the association between prenatal exposure to antiseizure medication and low birth weight in the offspring. Antidepressant exposure was associated with low birth weight, but there were no gene-drug interactions. The interplay between MRP2-ABCC2 and MDR1-ABCB1 variants and antiseizure medication may impact neonatal birth weight., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Telomere length in relation to fecundability and use of assisted reproductive technologies: the Norwegian mother, father, and child cohort study

  • Skåra, Karoline Hansen
  • Lee, Yunsung
  • Jugessur, Astanand
  • Gjessing, Håkon K.
  • Aviv, Abraham
  • Brumpton, Ben
  • Næss, Øyvind
  • Hernáez, Álvaro
  • Hanevik, Hans Ivar
  • Magnus, Per
  • Magnus, Maria Christine
Background Telomere length (TL) has been reported to be associated with conditions such as endometriosis and polycystic ovary syndrome, with some studies finding associations with shorter TL and others with longer TL. In men, studies mostly report associations between shorter TL and sperm quality. To our knowledge, no studies have thus far investigated associations between TL and fecundability or the use of assisted reproductive technologies (ART). Methods This study is based on the Norwegian Mother, Father, and Child Cohort (MoBa) Study and uses data from the Medical Birth Registry of Norway (MBRN). We included women (24,645 with genotype data and 1054 with TL measurements) and men (18,339 with genotype data and 965 with TL measurements) participating between 1998 and 2008. We investigated associations between leukocyte TL (LTL) and fecundability (defined as the probability to conceive within a given menstrual cycle), infertility (defined has having spent 12 months or more trying to conceive without success), and ART use. We also repeated the analyses using instrumental variables for LTL consisting of genetic risk scores for LTL and genetically predicted LTL. Results Approximately 11% of couples had experienced infertility and 4% had used ART. LTL was not associated with fecundability in women (fecundability ratio [FR], 0.98; 95% confidence interval [CI], 0.92–1.04) or men (FR, 0.99; CI, 0.93–1.06), nor with infertility in women (odds ratio [OR], 1.03; CI, 0.85–1.24) or men (OR, 1.05; CI, 0.87–1.28). We observed an increased likelihood of using ART with increasing LTL in men (OR, 1.22; CI, 1.03–1.46), but not in women (OR, 1.10; CI, 0.92–1.31). No significant associations were observed using the instrumental variables for LTL. Conclusions We found no indication that LTL is a suitable biomarker for assessing fecundability, infertility, or ART use. Additional studies are required to replicate the association observed between LTL and ART use in men., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Parental genetically predicted liability for coronary heart disease and risk of adverse pregnancy outcomes: a cohort study

  • Hernáez, Álvaro
  • Skåra, Karoline Hansen
  • Page, Christian Magnus
  • Mitter, Vera R.
  • Hernández Hernández, Marta
  • Magnus, Per
  • Njølstad, Pål R.
  • Andreassen, Ole A.
  • Corfeld, Elizabeth C.
  • Havdahl, Alexandra
  • Næss, Øyvind
  • Brumpton, Ben
  • Åsvold, Bjørn Olav
  • Lawlor, Deborah A.
  • Fraser, Abigail
  • Magnus, Maria Christine
Background Adverse pregnancy outcomes (APO) may unmask or exacerbate a woman’s underlying risk for coronary heart disease (CHD). We estimated associations of maternal and paternal genetically predicted liability for CHD with lifelong risk of APOs. We hypothesized that associations would be found for women, but not their male partners (negative controls). Methods We studied up to 83,969‬ women (and up to 55,568‬ male partners) from the Norwegian Mother, Father and Child Cohort Study or the Trøndelag Health Study with genotyping data and lifetime history of any APO in their pregnancies (1967–2019) in the Medical Birth Registry of Norway (miscarriage, stillbirth, hypertensive disorders of pregnancy, gestational diabetes, small for gestational age, large for gestational age, and spontaneous preterm birth). Maternal and paternal genetic risk scores (GRS) for CHD were generated using 148 gene variants (p-value < 5 × 10−8, not in linkage disequilibrium). Associations between GRS for CHD and each APO were determined using logistic regression, adjusting for genomic principal components, in each cohort separately, and combined using fixed effects meta-analysis. Results One standard deviation higher GRS for CHD in women was related to increased risk of any hypertensive disorders of pregnancy (odds ratio [OR] 1.08, 95% confidence interval [CI] 1.05–1.10), pre-eclampsia (OR 1.08, 95% CI 1.05–1.11), and small for gestational age (OR 1.04, 95% CI 1.01–1.06). Imprecise associations with lower odds of large for gestational age (OR 0.98, 95% CI 0.96–1.00) and higher odds of stillbirth (OR 1.04, 95% CI 0.98–1.11) were suggested. These findings remained consistent after adjusting for number of total pregnancies and the male partners’ GRS and restricting analyses to stable couples. Associations for other APOs were close to the null. There was weak evidence of an association of paternal genetically predicted liability for CHD with spontaneous preterm birth in female partners (OR 1.02, 95% CI 0.99–1.05), but not with other APOs. Conclusions Hypertensive disorders of pregnancy, small for gestational age, and stillbirth may unmask women with a genetically predicted propensity for CHD. The association of paternal genetically predicted CHD risk with spontaneous preterm birth in female partners needs further exploration., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cardiovascular disease risk factors and infertility: multivariable analyses and one-sample Mendelian randomization analyses in the Trøndelag Health Study

  • Skåra, Karoline Hansen
  • Hernáez, Álvaro
  • Næss, Øyvind
  • Fraser, Abigail
  • Lawlor, Deborah A.
  • Burgess, Stephen
  • Brumpton, Ben
  • Magnus, Maria Christine
STUDY QUESTION Are cardiovascular disease (CVD) risk factors causally associated with higher risk of infertility among women and men? SUMMARY ANSWER We found evidence to support a causal relationship between smoking initiation and history of infertility in women. WHAT IS KNOWN ALREADY Several CVD risk factors are associated with history of infertility. Previous studies using Mendelian randomization (MR) further support a causal relationship between BMI and infertility in women. STUDY DESIGN, SIZE, DURATION We used data from the Trøndelag Health Study (HUNT) in Norway, a prospective population-based cohort study, including 26 811 women and 15 598 men participating in three survey collections in 1995–1997 (HUNT2), 2006–2008 (HUNT3), and 2017–2019 (HUNT4). PARTICIPANTS/MATERIALS, SETTING, METHODS Our outcome was women’s self-reported history of infertility, defined as ever having tried to conceive for 12 months or more or having used ART. We assigned the history of infertility reported by women to their male partners; therefore, the measure of infertility was on the couple level. We used both conventional multivariable analyses and one-sample MR analyses to evaluate the association between female and male CVD risk factors (including BMI, blood pressure, lipid profile measurements, and smoking behaviours) and history of infertility in women and men, separately. MAIN RESULTS AND THE ROLE OF CHANCE A total of 4702 women (18%) and 2508 men (16%) were classified with a history of infertility. We found a higher risk of infertility among female smokers compared to non-smokers in both multivariable and MR analyses (odds ratio (OR) in multivariable analysis, 1.20; 95% CI, 1.12–1.28; OR in MR analysis, 1.13; CI, 1.02–1.26), and potentially for higher BMI (OR in multivariable analysis, 1.13; CI, 1.09–1.18; OR in MR analysis, 1.11, CI, 0.92–1.34). In multivariable analysis in women, we also found evidence of associations between triglyceride levels, high-density lipoprotein cholesterol, lifetime smoking index, and smoking intensity with higher risk of infertility. However, these results were not consistent in MR analyses. We found no robust or consistent associations between male CVD risk factors and infertility. LIMITATIONS, REASONS FOR CAUTION Our main limitation was that the CVD risk factors measured might not adequately capture the relevant time periods for when couples were trying to conceive. Additionally, we did not have information on causes of infertility in either women or men. WIDER IMPLICATIONS OF THE FINDINGS Women with infertility could have a worse CVD risk factor profile and thus public health interventions aimed at reducing the impact of some CVD risk factors, such as smoking and BMI, could reduce the burden of infertility. However, additional MR studies of the relationship between CVD risk factors and infertility with a larger sample size would be of value., info:eu-repo/semantics/publishedVersion